![Stephen Cunningham](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Cunningham
Directeur/Membre du Conseil chez Engrail Therapeutics, Inc.
Postes actifs de Stephen Cunningham
Sociétés | Poste | Début | Fin |
---|---|---|---|
Engrail Therapeutics, Inc.
![]() Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - |
Historique de carrière de Stephen Cunningham
Anciens postes connus de Stephen Cunningham
Sociétés | Poste | Début | Fin |
---|---|---|---|
Chase Pharmaceuticals Corp.
![]() Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Chase Pharmaceuticals Corp.
![]() Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Engrail Therapeutics, Inc.
![]() Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Stephen Cunningham
- Expérience